Jevtana 60 mg inf. sol. (conc. + solv.) i.v. vial 1.5 ml + 4.5 ml
Active ingredient: Cabazitaxel
View notice details →
News topic
All current shortage notices related to Start: 2027-07, structured by product, country, active ingredient and reporting period.
6 noticesActive ingredient: Cabazitaxel
View notice details →Active ingredient: Olodaterol
View notice details →Active ingredient: Ritonavir
View notice details →Active ingredient: Ritonavir
View notice details →Active ingredient: Lopinavir,Ritonavir
View notice details →Active ingredient: Ritonavir,Lopinavir
View notice details →For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.
Researching this shortage professionally? We assess sourcing routes, suppliers and cross-border supply against your requirements. A notice does not confirm stock availability.
Send a sourcing enquiry →Medicine storage, batch and expiry control, picking and distribution for Germany and Europe. We agree the storage profile, temperature and capacity with you.
Request warehouse capacity →